Our Funding Support
PROTEUS is grateful to its current and previous funders who have supported its efforts to advance the use of patient-reported outcomes.
Initial Consortium funding
The PROTEUS Consortium was established with funding from the following grant:
- “PROTEUS – Patient-Reported Outcome Tools: Engaging Users & Stakeholders” engagement award #12565 from the Patient-Centered Outcomes Research Institute (12/1/20218 – 11/30/2019)
Current Consortium Funding
The PROTEUS Consortium is currently funded through the following grants:
- “PROTEUS” independent education grant #69689683 from Pfizer (1/1/2022-12/31/2026)
- “Education & Engagement Strategies to Advance the Use of Patient-Reported Outcomes in Vulnerable and Underserved Populations” independent education grant #95657395 from Pfizer (12/2/2024-12/1/2026)
Previous Consortium Funding
The PROTEUS Consortium was previously funded through the following grants:
- “PROTEUS – Patient-Reported Outcome Tools: Engaging Users & Stakeholders” unrestricted grant G-69217 from Genentech, a member of the Roche Group (12/1/2019-12/31/2022)
- “PROTEUS-Practice” independent education grant #63470015 from Pfizer (10/1/2020-6/30/2023)
Related Projects
While the below funding did not directly support the Consortium, the projects were related to PROTEUS efforts:
- “PRO Implementation Grants Project” collaborative agreement with Pfizer to conduct a request for proposals for projects aiming to implement or improve implementation of PROs in oncology clinical practice (11/1/2021-10/31/2022)
- “Advisory Group for PROM Implementation in Underserved Populations” collaborative agreement with Pfizer to identify barriers to, and solutions for, implementing PROs across diverse patient groups (12/15/2022-6/30/2023)
- “Grants Project on the Value of Patient-Reported Outcomes” collaborative agreement with Pfizer to conduct a request for proposals for projects to investigate the monetary and non-monetary value of PROs in clinical practice (11/1/2023-10/31/2024)
- “PERC Summit on Patient-Reported Outcomes: Engaging Patients to Enhance the Use and Usefulness of PROs in Clinical Practice” contract with Johnson & Johnson to conduct a summit with patient advocates to obtain their input on optimizing the use of PROs in clinical practice (12/1/2025-12/31/2026)